Skip to main content
. Author manuscript; available in PMC: 2016 Mar 31.
Published in final edited form as: Bioorg Med Chem Lett. 2015 Jul 20;25(18):3933–3936. doi: 10.1016/j.bmcl.2015.07.034

Table 1.

Affinity and selectivity of FECIMBI-36

Targets Ki (nM) Targets Ki (nM)
5-HT1A 1433 D1 >10,000
5-HT1B >10,000 D2 1394
5-HT1D >10,000 D3 1076
5-HT1E >10,000 KAR >10,000
5-HT2A 1.0 D4 >1000
5-HT2B 2.8 D5 >10,000
5-HT2C 1.7 DAT >10,000
5-HT3 >10,000 DOR >10,000
5-HT7 >10,000 EP >10,000
Adenosine >10,000 GABA >10,000
α1A–1C >10,000 H4 2126
α2A 551 HERG >10,000
α2B 1256 KOR 558
α2C 656 M >10,000
β1 >10,000 H3, H4 >10,000
β2 3220 MDR1 >10,000
β3 >10,000 H2 1983
BZP >10,000 H1 150
Ca++ >10,000 MOR 149
AMPA >10,000 mGluR >10,000
NET 208 NMDA >10,000
NK >10,000 SERT 284
Sigma1 499 Sigma2 51
Na+ >10,000 NT1 >10,000
CB1, CB2 >10,000 I >10,000
mGluRs >10,000 VMAT >10,000
NOP >10,000 NMDA >10,000
PBR 876 NT >10,000
Oxytocin >10,000 PKC >10,000
Smoothened >10,000 V1–2 >10,000
Agonist assays 5-HT2AR 5-HT2BR 5-HT2CR
Emax: 63.4% Emax: 18.4% Emax: 100%